{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:56:58Z","timestamp":1790841418030,"version":"4.1.0"},"reference-count":29,"publisher":"American Association for Cancer Research (AACR)","issue":"10","funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA138313"],"award-info":[{"award-number":["P30 CA138313"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA006973"],"award-info":[{"award-number":["P30 CA006973"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011566","name":"Sidney Kimmel Comprehensive Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011566","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100023053","name":"College of Medicine, Medical University of South Carolina","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100023053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006806","name":"Hollings Cancer Center, Medical University of South Carolina","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006806","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Lipid metabolism is regarded as a hallmark of cancer. Sphingolipids, a family of structural and signaling lipids, have antiproliferative (ceramides) or prosurvival [sphingosine 1-phosphate (S1P)] functions. The positive association between statin use and bladder cancer, unlike other cancers, suggests that lipid metabolism not affected by HMG-CoA reductase inhibition may contribute uniquely to this cancer. We conducted a hypothesis-generating study investigating associations between plasma sphingolipid metabolic enzymes and bladder cancer incidence and mortality in the Atherosclerosis Risk in Communities study. Among 10,129 men and women with proteomic profiling of plasma collected in 1993 to 1995, 158 incident bladder cancer cases and 47 bladder cancer deaths were ascertained over a median of 20 years of follow-up (164,013 person-years). Cox regression was used to estimate hazard ratios (HR) and 95% confidence intervals (CI) for protein tertiles adjusted for age, race, sex, and known cancer risk factors, including smoking status, pack-years smoked, and cholesterol-lowering medication use. Of the six sphingolipid enzymes, sphingosine kinase 1 (SPHK1), involved in S1P synthesis, was associated with an increased risk of bladder cancer incidence [tertile 3 (T3) vs. T1: HR, 1.74; 95% CI, 1.15\u20132.63; P trend = 0.008] and bladder cancer mortality (T3 vs. T1: HR, 2.39; 95% CI, 1.02\u20135.61; P trend = 0.06). Associations for incidence were attenuated in lagged analyses, suggesting potential reverse causation, whereas associations for mortality were unchanged. Our findings suggest that sphingolipid metabolism, specifically enzymes involved in S1P synthesis, may contribute to bladder cancer etiology, with stronger associations in subgroups with lower cholesterol. These findings motivate confirmatory investigation of plasma S1P in relation to bladder cancer outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Prevention Relevance:<\/jats:title>\n                    <jats:p>We report a consistent positive association for SPHK1, involved in S1P metabolism, and bladder cancer risk and mortality in our prospective study. Stronger positive associations for SPHK1 were noted in subgroups with lower cholesterol, reflecting a shift in structural and\/or signaling lipids to influence bladder cancer initiation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/1940-6207.capr-25-0499","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T09:00:51Z","timestamp":1783328451000},"page":"565-576","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Proteomic Analysis of Sphingolipid Metabolic Enzymes with Risk of Bladder Cancer Incidence and Mortality in the Atherosclerosis Risk in Communities Study"],"prefix":"10.1158","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1568-9499","authenticated-orcid":false,"given":"Michael T.","family":"Marrone","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/012jban78","id-type":"ROR","asserted-by":"publisher"}],"name":"Medical University of South Carolina 1 Department of Public Health Sciences, , Charleston, South Carolina."},{"id":[{"id":"https:\/\/ror.org\/012jban78","id-type":"ROR","asserted-by":"publisher"}],"name":"Medical University of South Carolina 2 Hollings Cancer Center, , Charleston, South Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5455-9470","authenticated-orcid":false,"given":"Evan","family":"Bagley","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/012jban78","id-type":"ROR","asserted-by":"publisher"}],"name":"Medical University of South Carolina 1 Department of Public Health Sciences, , Charleston, South Carolina."},{"id":[{"id":"https:\/\/ror.org\/012jban78","id-type":"ROR","asserted-by":"publisher"}],"name":"Medical University of South Carolina 2 Hollings Cancer Center, , Charleston, South Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3198-8835","authenticated-orcid":false,"given":"Kenneth R.","family":"Butler","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/044pcn091","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Mississippi Medical Center 3 Department of Medicine, , Jackson, Mississippi."},{"id":[{"id":"https:\/\/ror.org\/044pcn091","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Mississippi Medical Center 4 Mind Center, , Jackson, Mississippi."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4313-9235","authenticated-orcid":false,"given":"David J.","family":"Couper","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/0130frc33","id-type":"ROR","asserted-by":"publisher"}],"name":"University of North Carolina at Chapel Hill 5 Department of Biostatistics, , Chapel Hill, North Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5100-172X","authenticated-orcid":false,"given":"Corinne E.","family":"Joshu","sequence":"additional","affiliation":[{"name":"6Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland."},{"name":"7Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3676-8954","authenticated-orcid":false,"given":"Elizabeth A.","family":"Platz","sequence":"additional","affiliation":[{"name":"6Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland."},{"name":"7Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland."},{"name":"8Department of Urology, James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1019-5660","authenticated-orcid":false,"given":"Besim","family":"Ogretmen","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/012jban78","id-type":"ROR","asserted-by":"publisher"}],"name":"Medical University of South Carolina 2 Hollings Cancer Center, , Charleston, South Carolina."},{"id":[{"id":"https:\/\/ror.org\/012jban78","id-type":"ROR","asserted-by":"publisher"}],"name":"Medical University of South Carolina 9 Department of Biochemistry and Molecular Biology, , Charleston, South Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"key":"2026100103092998900_bib1","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.addr.2020.07.013","article-title":"Lipids and cancer: emerging roles in pathogenesis, diagnosis and therapeutic intervention","volume":"159","author":"Butler","year":"2020","journal-title":"Adv Drug Deliv Rev"},{"key":"2026100103092998900_bib2","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.coph.2012.07.006","article-title":"Cholesterol and prostate cancer","volume":"12","author":"Pelton","year":"2012","journal-title":"Curr Opin Pharmacol"},{"key":"2026100103092998900_bib3","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.tem.2007.12.004","article-title":"Do the cholesterol-lowering properties of statins affect cancer risk?","volume":"19","author":"Solomon","year":"2008","journal-title":"Trends Endocrinol Metab"},{"key":"2026100103092998900_bib4","doi-asserted-by":"publisher","first-page":"pkab080","DOI":"10.1093\/jncics\/pkab080","article-title":"Lipid-lowering drug use and cancer incidence and mortality in the ARIC study","volume":"5","author":"Marrone","year":"2021","journal-title":"JNCI Cancer Spectr"},{"key":"2026100103092998900_bib5","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.tem.2017.03.005","article-title":"Sphingolipids and lipoproteins in health and metabolic disorders","volume":"28","author":"Iqbal","year":"2017","journal-title":"Trends Endocrinol Metab"},{"key":"2026100103092998900_bib6","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/nrc.2017.96","article-title":"Sphingolipid metabolism in cancer signalling and therapy","volume":"18","author":"Ogretmen","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"2026100103092998900_bib7","doi-asserted-by":"publisher","first-page":"e0216213","DOI":"10.1371\/journal.pone.0216213","article-title":"Differences in plasma levels of long chain and very long chain ceramides between African Americans and whites: an observational study","volume":"14","author":"Buie","year":"2019","journal-title":"PLoS One"},{"key":"2026100103092998900_bib8","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1111\/acel.12369","article-title":"Demographic and clinical variables affecting mid- to late-life trajectories of plasma ceramide and dihydroceramide species","volume":"14","author":"Mielke","year":"2015","journal-title":"Aging Cell"},{"key":"2026100103092998900_bib9","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrm1103","article-title":"Sphingosine-1-phosphate: an enigmatic signalling lipid","volume":"4","author":"Spiegel","year":"2003","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2026100103092998900_bib10","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1042\/bst0311216","article-title":"Exogenous and intracellularly generated sphingosine 1-phosphate can regulate cellular processes by divergent pathways","volume":"31","author":"Spiegel","year":"2003","journal-title":"Biochem Soc Trans"},{"key":"2026100103092998900_bib11","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.3390\/cells8121573","article-title":"Role of ceramidases in sphingolipid metabolism and human diseases","volume":"8","author":"Parveen","year":"2019","journal-title":"Cells"},{"key":"2026100103092998900_bib12","doi-asserted-by":"publisher","first-page":"41","DOI":"10.21873\/anticanres.13078","article-title":"Bioactive sphingolipids as biomarkers predictive of disease severity and treatment response in cancer: current status and translational challenges","volume":"39","author":"Sedi\u0107","year":"2019","journal-title":"Anticancer Res"},{"key":"2026100103092998900_bib13","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1126\/science.1153124","article-title":"Ceramide triggers budding of exosome vesicles into multivesicular endosomes","volume":"319","author":"Trajkovic","year":"2008","journal-title":"Science"},{"key":"2026100103092998900_bib14","doi-asserted-by":"publisher","first-page":"6956","DOI":"10.1038\/ncomms7956","article-title":"Enterobacteria-secreted particles induce production of exosome-like S1P-containing particles by intestinal epithelium to drive Th17-mediated tumorigenesis","volume":"6","author":"Deng","year":"2015","journal-title":"Nat Commun"},{"key":"2026100103092998900_bib15","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nature20792","article-title":"Genome-wide in vivo screen identifies novel host regulators of metastatic colonization","volume":"541","author":"van der Weyden","year":"2017","journal-title":"Nature"},{"key":"2026100103092998900_bib16","doi-asserted-by":"publisher","first-page":"111742","DOI":"10.1016\/j.celrep.2022.111742","article-title":"Crosstalk between pro-survival sphingolipid metabolism and complement signaling induces inflammasome-mediated tumor metastasis","volume":"41","author":"Janneh","year":"2022","journal-title":"Cell Rep"},{"key":"2026100103092998900_bib17","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.abb.2019.02.008","article-title":"NOD-like receptors and inflammasomes: a review of their canonical and non-canonical signaling pathways","volume":"670","author":"Platnich","year":"2019","journal-title":"Arch Biochem Biophys"},{"key":"2026100103092998900_bib18","doi-asserted-by":"publisher","first-page":"1122586","DOI":"10.3389\/fimmu.2023.1122586","article-title":"The role of NOD-like receptors in innate immunity","volume":"14","author":"Almeida-da-Silva","year":"2023","journal-title":"Front Immunol"},{"key":"2026100103092998900_bib19","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.trecan.2023.07.001","article-title":"Sphingolipid metabolism and complement signaling in cancer progression","volume":"9","author":"Janneh","year":"2023","journal-title":"Trends Cancer"},{"key":"2026100103092998900_bib20","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1038\/ni.1655","article-title":"Modulation of the antitumor immune response by complement","volume":"9","author":"Markiewski","year":"2008","journal-title":"Nat Immunol"},{"key":"2026100103092998900_bib21","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/s41568-019-0210-0","article-title":"Context-dependent roles of complement in cancer","volume":"19","author":"Roumenina","year":"2019","journal-title":"Nat Rev Cancer"},{"key":"2026100103092998900_bib22","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1093\/jn\/nxaa269","article-title":"Dietary patterns, ceramide ratios, and risk of all-cause and cause-specific mortality: the Framingham Offspring Study","volume":"150","author":"Walker","year":"2020","journal-title":"J Nutr"},{"key":"2026100103092998900_bib23","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1158\/1055-9965.EPI-12-1424","article-title":"Plasma sphingolipids and lung cancer: a population-based, nested case-control study","volume":"22","author":"Alberg","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2026100103092998900_bib24","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1158\/1055-9965.EPI-17-0696","article-title":"Enhancing the infrastructure of the Atherosclerosis Risk in Communities (ARIC) Study for cancer epidemiology research: ARIC cancer","volume":"27","author":"Joshu","year":"2018","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2026100103092998900_bib25","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s43587-021-00064-0","article-title":"Large-scale plasma proteomic analysis identifies proteins and pathways associated with dementia risk","volume":"1","author":"Walker","year":"2021","journal-title":"Nat Aging"},{"key":"2026100103092998900_bib26","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1161\/01.atv.14.7.1098","article-title":"Associations of lipoprotein cholesterols, apolipoproteins A-I and B, and triglycerides with carotid atherosclerosis and coronary heart disease. The Atherosclerosis Risk in Communities (ARIC) Study","volume":"14","author":"Sharrett","year":"1994","journal-title":"Arterioscler Thromb"},{"key":"2026100103092998900_bib27","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/978-1-4614-0650-1_9","article-title":"Sphingolipid synthetic pathways are major regulators of lipid homeostasis","volume":"721","author":"Worgall","year":"2011","journal-title":"Adv Exp Med Biol"},{"key":"2026100103092998900_bib28","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1002\/emmm.201200244","article-title":"Communication between host organism and cancer cells is transduced by systemic sphingosine kinase 1\/sphingosine 1-phosphate signalling to regulate tumour metastasis","volume":"4","author":"Ponnusamy","year":"2012","journal-title":"EMBO Mol Med"},{"key":"2026100103092998900_bib29","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/s41590-021-00886-5","article-title":"NLRP3 inflammasome in cancer and metabolic diseases","volume":"22","author":"Sharma","year":"2021","journal-title":"Nat Immunol"}],"container-title":["Cancer Prevention Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article-pdf\/doi\/10.1158\/1940-6207.CAPR-25-0499\/3810139\/capr-25-0499.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article-pdf\/doi\/10.1158\/1940-6207.CAPR-25-0499\/3813970\/capr-25-0499.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article-pdf\/19\/10\/565\/3832620\/capr-25-0499.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article-pdf\/19\/10\/565\/3832620\/capr-25-0499.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:09:53Z","timestamp":1790838593000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article\/19\/10\/565\/788511\/Proteomic-Analysis-of-Sphingolipid-Metabolic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":29,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,7,3]]},"published-print":{"date-parts":[[2026,10,1]]}},"URL":"https:\/\/doi.org\/10.1158\/1940-6207.capr-25-0499","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/1940-6207.34041143","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.34041155","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.34041152","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.34041164","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.34041161","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.34041173","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.34041170","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.34041149","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.34041167","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.34041146","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/1940-6207.c.8748188","asserted-by":"object"}]},"ISSN":["1940-6207","1940-6215"],"issn-type":[{"value":"1940-6207","type":"print"},{"value":"1940-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]}}}